What is Wavepaths?
Founded in 2019 and based in London, United Kingdom, Wavepaths operates at the intersection of music technology and psychedelic-assisted therapy. The company is developing innovative solutions aimed at enhancing therapeutic outcomes through carefully curated soundscapes designed to complement psychedelic experiences. This unique approach positions Wavepaths as a key player in the evolving landscape of mental health treatment.
How much funding has Wavepaths raised?
Wavepaths has raised a total of $4.5M across 1 funding round:
Angel/Seed
$4.5M
Angel/Seed (2021): $4.5M, investors not publicly disclosed
What's next for Wavepaths?
The recent major strategic investment signals a pivotal growth phase for Wavepaths. This capital infusion is expected to fuel further research and development, potentially expanding the company's therapeutic offerings and market reach. As the psychedelic therapy sector continues to mature, Wavepaths appears poised to leverage this financing to solidify its position and drive innovation in creating accessible and effective mental wellness solutions.
See full Wavepaths company page
